Skip to content

Category Archives: Medications

Scientists discover better way of transforming skin cells to stem cells

01-Oct-10

Harvard scientists were able to establish a better way to transform skin cells into stem cells.

Previous method of transforming skin cells to stems cells has made some adverse reaction to new formed cells. The previous method would more Continue....

Drug company GSK announces dropping of herpes vaccine trials

01-Oct-10

GlaxoSmithKline (GSK) announced today that they will no longer continue the clinical trials of the company’s experimental herpes vaccine Simplirix.

Simplirix is a vaccine the pharmaceutical company GSK developed to help people prevent Continue....

New painkilling drug shows significant efficacy in managing osteoarthritis knee pain

30-Sep-10

Researchers found that the painkilling drug tanezumab greatly reduced knee pain in patients experiencing osteoarthritis.

Amid the success of tanezumab in the clinical trials, the U.S. Food and Drug Agency (FDA) ordered the company Continue....

FDA warns mouthwash companies about products’ health claims

29-Sep-10

The U.S. Food and Drug Administration (FDA) issued warnings to three companies about the health benefits claims of their mouthwash products.

The federal regulatory warned Johnson & Johnson, CVS Caremark, and Walgreen about their Continue....

FDA approves an upgraded version of contraceptive pill

28-Sep-10

The U.S. Food and Drug Administration (FDA) approved the use of Beyaz, which is an upgraded version YAZ, as an oral contraceptive.

Beyaz, which Bayer HealthCare Pharmaceuticals based from their contraceptive pill YAZ, is a combined oral Continue....

Drug for hard-to-treat breast cancer subtype shows great potential

27-Sep-10

Researchers found that the trials of a drug for a type of breast cancer that is hard to treat showed great results.

Triple Negative Breast Cancer is a subtype of breast cancer that affects one out of seven women with the breast cancer. Continue....

Oral preparation of MS drug gains FDA approval

23-Sep-10

The multiple sclerosis (MS) drug Gilenya (fingolimod) achieved the approval of the U.S. Food and Drug Agency (FDA).

Novartis, the company who developed Gilenya, announced that the FDA approved the use of 0.5 mg capsule for the treatment of Continue....

FDA to review Pioglitazone regarding increased risk of bladder cancer

20-Sep-10

The U.S. Food and Drug Agency (FDA) will conduct studies that will clear issues about the drug Pioglitazone causing increased bladder cancer risk.

Pioglitazone (Actos) is a drug used by diabetic people to control blood sugar level. There Continue....

Kidney cancer drug to treat advanced thyroid cancer, study says

20-Sep-10

A U.S. study says that a drug used in the treatment of kidney cancer can also treat advanced thyroid cancer.

According to the study, posted in The Lancet Oncology online, the anti-kidney cancer drug Pazopanib (Votrient) showed potentials in Continue....

FDA panel approves the use of Vivitrol in opioid addiction treatment

17-Sep-10

An advisory panel of the U.S. Food and Drugs Agency (FDA) agreed to recommend the indication of Vivitrol for opioid dependence.

The FDA panel, which is composed of outside experts, said they saw the drug to be safe and effective after the Continue....